Cargando…
Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury
BACKGROUND: Neuropathic pain is a multifaceted and ubiquitous disease across the globe. Mood disorders, such as anxiety and depression, are frequently observed in patients suffering from neuropathic pain. Both neuropathic pain and comorbid mood disorders seriously impact quality of life. Accumulated...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816674/ https://www.ncbi.nlm.nih.gov/pubmed/33000169 http://dx.doi.org/10.1093/ijnp/pyaa076 |
_version_ | 1783638490045480960 |
---|---|
author | Liu, Pei Chen, Jianjun Ma, Shuai Zhang, Jianjun Zhou, Jianyu |
author_facet | Liu, Pei Chen, Jianjun Ma, Shuai Zhang, Jianjun Zhou, Jianyu |
author_sort | Liu, Pei |
collection | PubMed |
description | BACKGROUND: Neuropathic pain is a multifaceted and ubiquitous disease across the globe. Mood disorders, such as anxiety and depression, are frequently observed in patients suffering from neuropathic pain. Both neuropathic pain and comorbid mood disorders seriously impact quality of life. Accumulated evidence shows that activation of the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the neuroinflammatory pathogenesis of neuropathic pain, anxiety, and depression. However, the role of the NLRP3 inflammasome in the pathological process of anxiety and depression under the neuropathic pain state has not been fully described. Albiflorin, a monoterpene glycoside, may be a potential regulator of the NLRP3 inflammasome, but it is not clear whether albiflorin relates to NLRP3 inflammasome activation. METHODS: We used a systematic pharmacological method to confirm whether the activation of the NLRP3 inflammasome in the hippocampus was involved in the development of neuropathic pain associated with mood disorders and whether albiflorin could be an effective treatment for these symptoms. RESULTS: The NLRP3 inflammasome contributed to the neuropathic pain and comorbid anxiety and depression-like behaviors induced by chronic constriction injury of the sciatic nerve, and albiflorin may relieve these symptoms via inhibition of the NLRP3 inflammasome activity. Moreover, albiflorin enhanced the translocation of the nuclear factor erythroid 2-related factor 2 into the nucleus and suppressed nuclear factor-kappa B activity in the hippocampus. CONCLUSIONS: Albiflorin, as a potential therapeutic agent, might greatly improve the overall symptoms of neuropathic pain. |
format | Online Article Text |
id | pubmed-7816674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-78166742021-01-26 Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury Liu, Pei Chen, Jianjun Ma, Shuai Zhang, Jianjun Zhou, Jianyu Int J Neuropsychopharmacol Regular Research Articles BACKGROUND: Neuropathic pain is a multifaceted and ubiquitous disease across the globe. Mood disorders, such as anxiety and depression, are frequently observed in patients suffering from neuropathic pain. Both neuropathic pain and comorbid mood disorders seriously impact quality of life. Accumulated evidence shows that activation of the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the neuroinflammatory pathogenesis of neuropathic pain, anxiety, and depression. However, the role of the NLRP3 inflammasome in the pathological process of anxiety and depression under the neuropathic pain state has not been fully described. Albiflorin, a monoterpene glycoside, may be a potential regulator of the NLRP3 inflammasome, but it is not clear whether albiflorin relates to NLRP3 inflammasome activation. METHODS: We used a systematic pharmacological method to confirm whether the activation of the NLRP3 inflammasome in the hippocampus was involved in the development of neuropathic pain associated with mood disorders and whether albiflorin could be an effective treatment for these symptoms. RESULTS: The NLRP3 inflammasome contributed to the neuropathic pain and comorbid anxiety and depression-like behaviors induced by chronic constriction injury of the sciatic nerve, and albiflorin may relieve these symptoms via inhibition of the NLRP3 inflammasome activity. Moreover, albiflorin enhanced the translocation of the nuclear factor erythroid 2-related factor 2 into the nucleus and suppressed nuclear factor-kappa B activity in the hippocampus. CONCLUSIONS: Albiflorin, as a potential therapeutic agent, might greatly improve the overall symptoms of neuropathic pain. Oxford University Press 2020-09-30 /pmc/articles/PMC7816674/ /pubmed/33000169 http://dx.doi.org/10.1093/ijnp/pyaa076 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Regular Research Articles Liu, Pei Chen, Jianjun Ma, Shuai Zhang, Jianjun Zhou, Jianyu Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury |
title | Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury |
title_full | Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury |
title_fullStr | Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury |
title_full_unstemmed | Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury |
title_short | Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury |
title_sort | albiflorin attenuates mood disorders under neuropathic pain state by suppressing the hippocampal nlrp3 inflammasome activation during chronic constriction injury |
topic | Regular Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816674/ https://www.ncbi.nlm.nih.gov/pubmed/33000169 http://dx.doi.org/10.1093/ijnp/pyaa076 |
work_keys_str_mv | AT liupei albiflorinattenuatesmooddisordersunderneuropathicpainstatebysuppressingthehippocampalnlrp3inflammasomeactivationduringchronicconstrictioninjury AT chenjianjun albiflorinattenuatesmooddisordersunderneuropathicpainstatebysuppressingthehippocampalnlrp3inflammasomeactivationduringchronicconstrictioninjury AT mashuai albiflorinattenuatesmooddisordersunderneuropathicpainstatebysuppressingthehippocampalnlrp3inflammasomeactivationduringchronicconstrictioninjury AT zhangjianjun albiflorinattenuatesmooddisordersunderneuropathicpainstatebysuppressingthehippocampalnlrp3inflammasomeactivationduringchronicconstrictioninjury AT zhoujianyu albiflorinattenuatesmooddisordersunderneuropathicpainstatebysuppressingthehippocampalnlrp3inflammasomeactivationduringchronicconstrictioninjury |